SciVision Biotech Inc (1786) — Cash Flow-to-Debt Ratio
SciVision Biotech Inc (1786) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of NT$48.51 Million could theoretically repay 0% of its total liabilities (NT$892.04 Million) in one year. See 1786 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SciVision Biotech Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for SciVision Biotech Inc across 17 annual periods. For the full cash flow conversion analysis, see 1786 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for SciVision Biotech Inc (2009–2025)
Year-by-year debt coverage analysis for SciVision Biotech Inc. Check earnings quality score of SciVision Biotech Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | NT$123.99 Million | NT$689.35 Million | ▼ -69.5% |
| 2024 | 0.59x | NT$269.87 Million | NT$457.43 Million | ▲ +15.7% |
| 2023 | 0.51x | NT$272.01 Million | NT$533.66 Million | ▲ +68.0% |
| 2022 | 0.30x | NT$178.21 Million | NT$587.30 Million | ▲ +150.1% |
| 2021 | 0.12x | NT$98.51 Million | NT$812.06 Million | ▼ -53.3% |
| 2020 | 0.26x | NT$126.47 Million | NT$486.55 Million | ▼ -36.3% |
| 2019 | 0.41x | NT$204.40 Million | NT$501.08 Million | ▲ +125.6% |
| 2018 | 0.18x | NT$111.70 Million | NT$617.70 Million | ▲ +634.2% |
| 2017 | 0.02x | NT$15.98 Million | NT$648.72 Million | ▼ -70.2% |
| 2016 | 0.08x | NT$38.29 Million | NT$462.93 Million | ▼ -79.4% |
| 2015 | 0.40x | NT$49.81 Million | NT$124.16 Million | ▲ +1390.5% |
| 2014 | 0.03x | NT$1.85 Million | NT$68.81 Million | ▼ -96.7% |
| 2013 | 0.82x | NT$37.27 Million | NT$45.23 Million | ▼ -8.3% |
| 2012 | 0.90x | NT$51.52 Million | NT$57.31 Million | ▼ -2.7% |
| 2011 | 0.92x | NT$37.13 Million | NT$40.17 Million | ▲ +1401.7% |
| 2010 | 0.06x | NT$6.85 Million | NT$111.24 Million | ▲ +117.8% |
| 2009 | -0.35x | NT$-36.09 Million | NT$104.31 Million | — |